Burg, Larry
Crewe, Gretel
DiMeo, James
Guo, Xin
Li, Carmen G.
Mayol, Melissa
Tempesta, Andrew
Lauzier, William
Markham, Rachelle
Crissy, Katarzyna
Barry, Colleen
Walsh, Bruce
Kirby, James E.
Straus, Don
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (1R01AI117058-01, >1R44AI157672-01)
U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority (#HHSO100201500022C)
Article History
Received: 22 July 2022
Accepted: 19 October 2022
First Online: 15 November 2022
Competing interests
: L.B., G.C., J.DiM., X.G. C.G.L., M.M., A.T., W.L., R.M., K.C., C.B., B.W. and D.S. are current or former employees of First Light Diagnostics. D.S. is a board member and shareholder of First Light Diagnostics. J.E.K. is a consultant for First Light Diagnostics and a member of its Clinical Advisory Board.